Marine Natural Products: From Sea to Pharmacy | Ocean Science Lecture

Added:

Chemical Language
Ecological Roles
Drug Discovery
Microbial Source
Key Molecule
New Approach
Evolution & Outreach

Chemical Language

2:06
Playing Section
  • 1

    Focuses on marine bacteria producing natural products.

  • 2

    Explores species, biogeography, and chemical ecology.

  • 3

    Highlights potential applications in drug discovery.

Introduction to Organic Chemistry: Understanding chemical structures, functional groups, and secondary metabolites (natural products) produced by organisms.
Basic Microbiology and Marine Biology: Familiarity with marine ecosystems, biodiversity, and the physiological adaptations of marine microbes and invertebrates.
Fundamentals of Genetics and Molecular Biology: Core concepts of DNA sequencing, gene expression, and how genetic code dictates the synthesis of proteins and molecules.
The Drug Discovery Pipeline: General knowledge of how therapeutic agents are identified, tested, and approved for clinical use.
Advanced Bioinformatics and Genome Mining: Learning to use computational tools (such as antiSMASH) to identify biosynthetic gene clusters (BGCs) in microbial genomes.
Marine Pharmacology and Mechanisms of Action: Investigating how specific FDA-approved marine drugs (e.g., cytarabine, eribulin, brentuximab vedotin) target diseases at the cellular level.
Synthetic Biology and Metabolic Engineering: Exploring methods to heterologously express silent biosynthetic pathways in host organisms to scale up production of scarce marine compounds.
The Supply Problem and Sustainable Bioprospecting: Studying the ecological, chemical, and ethical challenges of sourcing marine natural products, including the impact of the Nagoya Protocol on international biodiversity sharing.
24.4K views558likes51:10@uctvOriginal Release: 2019-09-03

Marine microbes, particularly ocean-dwelling actinomycetes like Salinispora species, produce unique secondary metabolites that serve ecological functions such as defense and chemical communication, and these compounds represent a promising but underexplored source of new pharmaceuticals, with Salinisporamide A from Salinispora tropica currently in phase 3 clinical trials for cancer treatment as the first marine microbial natural product to reach this stage.